Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

Alzheimer's disease (AD) is a neurodegenerative condition characterized by a gradual decline in cognitive functions. Currently, there are no effective treatments for AD, underscoring the importance of identifying individuals in the preclinical stages of mild cognitive impairment (MCI) to enable...

Full description

Bibliographic Details
Published in:	Frontiers in Neuroscience
Main Authors:	Fernando García-Gutiérrez, Marta Marquié, Nathalia Muñoz, Montserrat Alegret, Amanda Cano, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Raquel Puerta, Adelina Orellana, Laura Montrreal, Vanesa Pytel, Mario Ricciardi, Carla Zaldua, Peru Gabirondo, Wolfram Hinzen, Núria Lleonart, Ainhoa García-Sánchez, Lluís Tárraga, Agustín Ruiz, Mercè Boada, Sergi Valero
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Subjects:	Alzheimer's disease mild cognitive impairment early diagnosis cerebrospinal fluid biomarkers machine learning
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1221401/full

Similar Items

Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum
by: Fernando García-Gutiérrez, et al.
Published: (2024-02-01)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
by: Pascual Sánchez-Juan, et al.
Published: (2019-12-01)

Federated learning for cognitive impairment detection using speech data
by: Josep Blazquez-Folch, et al.
Published: (2025-10-01)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
by: Natalia Roberto, et al.
Published: (2021-12-01)

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
by: Silvia Alonso-Lana, et al.
Published: (2020-10-01)

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort
by: Nathalia Muñoz, et al.
Published: (2020-01-01)

Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort
by: María Eugenia Sáez, et al.
Published: (2024-02-01)

Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia
by: Xavier Morató, et al.
Published: (2024-12-01)

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinicResearch in context
by: Amanda Cano, et al.
Published: (2024-10-01)

Exploring sex differences in Alzheimer’s disease: a comprehensive analysis of a large patient cohort from a memory unit
by: Maitee Rosende-Roca, et al.
Published: (2025-01-01)

Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
by: Amanda Cano, et al.
Published: (2021-10-01)

Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
by: Ainhoa García-Sánchez, et al.
Published: (2024-02-01)

Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort
by: Luis Castilla-Martí, et al.
Published: (2024-11-01)

Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
by: Marta Marquié, et al.
Published: (2020-03-01)

The linguistics of schizophrenia: thought disturbance as language pathology across positive symptoms
by: Wolfram eHinzen, et al.
Published: (2015-07-01)

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
by: Amanda Cano, et al.
Published: (2021-04-01)

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
by: Xavier Morató, et al.
Published: (2023-04-01)

What Is Un-Cartesian Linguistics?
by: Wolfram Hinzen
Published: (2014-10-01)

Prospects for an Explanatory Theory of Semantics
by: Wolfram Hinzen
Published: (2008-12-01)

Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
by: Laia Gutierrez-Tordera, et al.
Published: (2024-01-01)

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment
by: Shahzad Ahmad, et al.
Published: (2024-07-01)

Recursion as a Human Universal and as a Primitive
by: Boban Arsenijevic, et al.
Published: (2010-09-01)

Grammar in 'agrammatical' aphasia: What's intact?
by: Han Zhang, et al.
Published: (2022-01-01)

White matter microstructure of language pathways in non-verbal autism: insights from diffusion tensor imaging and myelin water imaging
by: Dominika Slušná, et al.
Published: (2025-08-01)

Mite i logos al Timeu de Plató
by: Lluís Alegret
Published: (1995-01-01)

Gerard VILAR, Indivdualisme, ètica i política.
by: Lluís Alegret
Published: (1995-04-01)

Relations between language, non-verbal cognition, and conceptualization in non- or minimally verbal individuals with ASD across the lifespan
by: Dominika Slušná, et al.
Published: (2021-11-01)

The Character of Mind
by: Wolfram Hinzen, et al.
Published: (2011-09-01)

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
by: Amanda Cano, et al.
Published: (2023-01-01)

Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort
by: Matteo Tonietto, et al.
Published: (2024-11-01)

Reflexions sobre el comentari de text filosòfic
by: Lluís Alegret i Biosca
Published: (1995-04-01)

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels
by: Ricardo Gonzalo, et al.
Published: (2024-12-01)

Aproximació a l'activitat pesquera a la regió de l'Empordà (segles XV-XVIII): adaptacions a un medi constant en transformació
by: Joan Lluís Alegret, et al.
Published: (2021-02-01)

The use of plasma exchange with albumin replacement in the management of Alzheimer’s disease: a scoping review
by: Yahveth Cantero-Fortiz, et al.
Published: (2024-09-01)

Corrigendum: The use of plasma exchange with albumin replacement in the management of Alzheimer's disease: a scoping review
by: Yahveth Cantero-Fortiz, et al.
Published: (2024-10-01)

The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer’s, and Parkinson’s disease’
by: Yahveth Cantero-Fortiz, et al.
Published: (2024-10-01)

Linguistic markers of autism spectrum conditions in narratives: A comprehensive analysis
by: Kristen Schroeder, et al.
Published: (2023-04-01)

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
by: Ana-María Lacosta, et al.
Published: (2018-01-01)

How to assess the level of dependency in an integrated health care system. The andorran experience
by: Anna Boada-Pladellorens, et al.
Published: (2018-01-01)

ADULT AND HIGHER EDUCATION AS LIFELONG LEARNING FOR SUSTAINABLE DEVELOPMENT. SOME BIOGRAPHICAL REFLECTIONS ON RECEIVING THE DOCTOR HONORIS CAUSA TITLE FROM THE MOLDOVA STATE UNIVERSITY
by: Heribert HINZEN
Published: (2020-02-01)